Nasal Drug Delivery Technology Market (By Dosage Form: Spray, Drops, Gel, Powder; By Container Type: Pressurized, Non-pressurized; By Therapeutic Application: Nasal Congestion, Rhinitis, Asthma, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 160

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
       1.1.1. Definition of Nasal Drug Delivery Technology
       1.1.2. Market Segmentation
       1.1.3. List of Abbreviations
1.2. Summary
       1.2.1. Market Snapshot
       1.2.2. Nasal Drug Delivery Technology Market By Dosage Form
                 1.2.2.1. Global Nasal Drug Delivery Technology Market Revenue and Growth Rate Comparison By Dosage Form (2015-2026)
                 1.2.2.2. Global Nasal Drug Delivery Technology Market Revenue Share By Dosage Form in 2017
                 1.2.2.3. Spray
                 1.2.2.4. Drops
                 1.2.2.5. Gel
                 1.2.2.6. Powder
                 1.2.2.7. Others
       1.2.3. Nasal Drug Delivery Technology Market By Container Type
                 1.2.3.1. Global Nasal Drug Delivery Technology Market Revenue and Growth Rate Comparison By Container Type (2015-2026)
                 1.2.3.2. Pressurized
                 1.2.3.3. Non-pressurized
                 1.2.3.4. Others
       1.2.4. Nasal Drug Delivery Technology Market By Therapeutic Application
                 1.2.4.1. Global Nasal Drug Delivery Technology Market Revenue and Growth Rate Comparison By Therapeutic Application (2015-2026)
                 1.2.4.2. Nasal Congestion
                 1.2.4.3. Rhinitis
                 1.2.4.4. Asthma
                 1.2.4.5. Others
       1.2.5. Nasal Drug Delivery Technology Market by Geography
                 1.2.5.1. Global Nasal Drug Delivery Technology Market Revenue and Growth Rate Comparison by Geography (2015-2026)
                 1.2.5.2. North America Nasal Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
                 1.2.5.3. Europe Nasal Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
                 1.2.5.4. Asia-Pacific Nasal Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
                 1.2.5.5. Latin America Nasal Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
                 1.2.5.6. Middle East and Africa (MEA) Nasal Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
       2.4.1. Bargaining Power of Suppliers
       2.4.2. Bargaining Power of Buyers
       2.4.3. Threat of Substitute
       2.4.4. Threat of New Entrants
       2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
       2.6.1. Raw Material and Suppliers
       2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
       2.8.1. Player Positioning Analysis
       2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Nasal Drug Delivery Technology Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Nasal Drug Delivery Technology Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Nasal Drug Delivery Technology Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Nasal Drug Delivery Technology Major Manufacturers in 2017

CHAPTER 4. NASAL DRUG DELIVERY TECHNOLOGY MARKET BY DOSAGE FORM

4.1. Global Nasal Drug Delivery Technology Revenue By Dosage Form
4.2. Spray
       4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Drops
       4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Gel
       4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Powder
       4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Other
       4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NASAL DRUG DELIVERY TECHNOLOGY MARKET BY CONTAINER TYPE

5.1. Global Nasal Drug Delivery Technology Revenue By Container Type
5.2. Pressurized
       5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Non-pressurized
       5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
       5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NASAL DRUG DELIVERY TECHNOLOGY MARKET BY THERAPEUTIC APPLICATION

6.1. Global Nasal Drug Delivery Technology Revenue By Therapeutic Application
6.2. Nasal Congestion
       6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Rhinitis
       6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Asthma
       6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others
       6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY

7.1. North America Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
       7.3.1. U.S. Nasal Drug Delivery Technology Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       7.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
       7.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
7.4. Canada
       7.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       7.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
       7.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
7.5. Mexico
       7.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       7.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
       7.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY

8.1. Europe Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
       8.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       8.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
       8.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
8.4. Germany
       8.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       8.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
       8.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
8.5. France
       8.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       8.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
       8.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
8.6. Spain
       8.6.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       8.6.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
       8.6.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
8.7. Rest of Europe
       8.7.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       8.7.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
       8.7.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY

9.1. Asia-Pacific Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
       9.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       9.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
       9.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
9.4. Japan
       9.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       9.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
       9.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
9.5. India
       9.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       9.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
       9.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
9.6. Australia
       9.6.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       9.6.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
       9.6.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
9.7. South Korea
       9.7.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       9.7.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
       9.7.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
       9.8.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       9.8.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
       9.8.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY

10.1. Latin America Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
         10.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
         10.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
         10.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
10.4. Argentina
         10.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
         10.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
         10.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
10.5. Rest of Latin America
         10.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
         10.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
         10.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY

11.1. Middle East Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
         11.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
         11.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
         11.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
11.4. UAE
         11.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
         11.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
         11.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
11.5. Rest of Middle East
         11.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
         11.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
         11.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY

12.1. Africa Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
         12.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
         12.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
         12.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
12.4. Egypt
         12.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
         12.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
         12.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
12.5. Rest of Africa
         12.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
         12.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
         12.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. NAVEH Pharma Ltd.
         13.1.1. Company Snapshot
         13.1.2. Overview
         13.1.3. Financial Overview
         13.1.4. Type Portfolio
         13.1.5. Key Developments
         13.1.6. Strategies
13.2. GlaxoSmithKline PLC
         13.2.1. Company Snapshot
         13.2.2. Overview
         13.2.3. Financial Overview
         13.2.4. Type Portfolio
         13.2.5. Key Developments
         13.2.6. Strategies
13.3. ENT Technologies Pty. Ltd.
         13.3.1. Company Snapshot
         13.3.2. Overview
         13.3.3. Financial Overview
         13.3.4. Type Portfolio
         13.3.5. Key Developments
         13.3.6. Strategies
13.4. AstraZeneca PLC
         13.4.1. Company Snapshot
         13.4.2. Overview
         13.4.3. Financial Overview
         13.4.4. Type Portfolio
         13.4.5. Key Developments
         13.4.6. Strategies
13.5. Douglas Pharmaceuticals Ltd.
         13.5.1. Company Snapshot
         13.5.2. Overview
         13.5.3. Financial Overview
         13.5.4. Type Portfolio
         13.5.5. Key Developments
         13.5.6. Strategies
13.6. Pfizer, Inc.
         13.6.1. Company Snapshot
         13.6.2. Overview
         13.6.3. Financial Overview
         13.6.4. Type Portfolio
         13.6.5. Key Developments
         13.6.6. Strategies
13.7. PendoPharm, Inc.
         13.7.1. Company Snapshot
         13.7.2. Overview
         13.7.3. Financial Overview
         13.7.4. Type Portfolio
         13.7.5. Key Developments
         13.7.6. Strategies
13.8. OptiNose, Inc.
         13.8.1. Company Snapshot
         13.8.2. Overview
         13.8.3. Financial Overview
         13.8.4. Type Portfolio
         13.8.5. Key Developments
         13.8.6. Strategies
13.9. B.F. Ascher & Company, Inc.
         13.9.1. Company Snapshot
         13.9.2. Overview
         13.9.3. Financial Overview
         13.9.4. Type Portfolio
         13.9.5. Key Developments
         13.9.6. Strategies
13.10. Becton
          13.10.1. Company Snapshot
          13.10.2. Overview
          13.10.3. Financial Overview
          13.10.4. Type Portfolio
          13.10.5. Key Developments
          13.10.6. Strategies
13.11. Dickinson and Company
          13.11.1. Company Snapshot
          13.11.2. Overview
          13.11.3. Financial Overview
          13.11.4. Type Portfolio
          13.11.5. Key Developments
          13.11.6. Strategies
13.12. Cadila Pharmaceuticals Ltd.
          13.12.1. Company Snapshot
          13.12.2. Overview
          13.12.3. Financial Overview
          13.12.4. Type Portfolio
          13.12.5. Key Developments
          13.12.6. Strategies
13.13. Promius Pharma, LLC.
          13.13.1. Company Snapshot
          13.13.2. Overview
          13.13.3. Financial Overview
          13.13.4. Type Portfolio
          13.13.5. Key Developments
          13.13.6. Strategies
13.14. Others
          13.14.1. Company Snapshot
          13.14.2. Overview
          13.14.3. Financial Overview
          13.14.4. Type Portfolio
          13.14.5. Key Developments
          13.14.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
        14.1.1. Initial Data Search
        14.1.2. Secondary Research
        14.1.3. Primary Research
14.2. Assumptions and Scope

Cart Summary